Timely COVID-19 treatment with oral antiviral agents is important for high-risk ambulatory patients. However, several factors need to be considered before prescribing oral antivirals to a patient with COVID-19.
Read my answers to questions about treatment recommendations and drug therapy considerations for ambulatory patients with acute COVID-19.
Read my answers to questions about assessment and treatment of nonhospitalized patients with acute COVID-19.
BIPOC communities are disproportionately affected by COVID-19. Read my take on strategies to minimize COVID-19 inequities.